CSL Behring Canada
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
55 Metcalfe St Suite 1460, Ottawa, Ontar...Phone Number
(815) 932-6771Website
www.cslbehring.caRevenue
$18.1 MillionIndustry
About CSL Behring Canada
CSL Behring Canada specializes in innovative medicines, offering a diverse portfolio of recombinant and plasma-derived products aimed at treating rare and serious diseases such as bleeding disorders, immune deficiencies, and chronic inflammatory demyelinating polyneuropathy. The company is dedicated to improving the quality of life for patients with conditions like hereditary angioedema and Alpha-1 Antitrypsin Deficiency. Their mission includes discovering, developing, and delivering therapies that ensure patients receive the necessary treatments. CSL Behring Canada actively supports research and development initiatives to advance medical knowledge in their field.Explore more
CSL Behring Canada Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to CSL Behring Canada
Compare insights from companies similar to CSL Behring Canada, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CSL Behring Canada
$18.1M
11-50
Private
-
-
MM
Michael McAllisterAt Csl Behring Head of Finance & Operations (Canada)
CSL Behring Canada Tech Stack
A closer look at the technologies used by CSL Behring Canada
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding CSL Behring Canada
Sign Up For FreeTo access detailed company insights
CSL Behring Canada specializes in innovative medicines, offering a diverse portfolio of recombinant and plasma-derived products aimed at treating rare and serious diseases such as bleeding disorders, immune deficiencies, and chronic inflammatory demyelinating polyneuropathy. The company is dedicated to improving the quality of life for patients wit... Read More
